R & D- medical: biomedical (basic research) award of task order "optimization and further development of mesothelin vaccine for the prevention of ovarian cancer"
Ended Awarded Last action
- Contract number
- HHSN26100003
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $712,240
Award facts
- Opportunity
-
- N01CN5500347 Solicitation number
- Preclinical PREVENT Cancer Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers Award Notice · Posted Sep 25, 2015
- Preclinical PREVENT Cancer Program for Preclinical Efficacy and Intermediate Endpoint Biomarkers Award Notice · Posted Jan 5, 2015
- Contract value 100% obligated
- $712,240.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Menlo Park, CA 94025, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $712,240 |
About this award
This is a $712,240 firm fixed-price delivery order awarded to SRI International, a non-profit research and development institute, by the National Cancer Institute (NCI). The contract is part of the NCI's Preclinical Prevention Cancer Program and supports the "Optimization and Further Development of Mesothelin Vaccine for the Prevention of Ovarian Cancer" project. This R&D effort focuses on basic biomedical research towards developing a preventive vaccine for ovarian cancer. The contract does not have a small business set-aside. SRI International is an experienced federal contractor, frequently serving as both a prime and subcontractor on government R&D projects across various scientific and engineering domains.
Quick answers
Who was awarded contract HHSN26100003?
HHSN26100003 was awarded to Sri International by National Cancer Institute (National Institutes of Health) on September 1, 2016.
How much is contract HHSN26100003 worth?
The government has obligated $712,240 on HHSN26100003.
Is contract HHSN26100003 an order under another contract?
Yes. HHSN26100003 is a delivery order under HHSN261201500041I, an indefinite delivery contract, on PREVENT Cancer Program (PREVENT).
Was contract HHSN26100003 competed?
The extent of competition for HHSN26100003 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award